MarketPulse
I

$INO

40 articles found
0 positive
40 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Inovio Investors Face April 7 Deadline in Securities Class Action Over Alleged Misstatements

Rosen Law Firm alerts $INO investors of April 7, 2026 deadline to join class action over alleged false statements regarding manufacturing and regulatory prospects.
INOsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Pomerantz Files Securities Fraud Suit Against $INO Over FDA Approval Misstatements

Pomerantz LLP sues Inovio Pharmaceuticals for alleged securities fraud over FDA approval misstatements. Stock fell 3.1% and 24.45% following manufacturing delays and accelerated approval rejection.
INOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Inovio Pharmaceuticals Hit with Securities Fraud Suit Over FDA Claims

Law firm Levi & Korsinsky files class action against Inovio Pharmaceuticals for allegedly false statements regarding device manufacturing and FDA pathways from October 2023 to December 2025.
INOsecurities class actionmisrepresentation
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Inovio Faces Securities Class Action Over Vaccine Device Defects, Regulatory Claims

Rosen Law Firm seeks lead plaintiffs in securities class action against Inovio Pharmaceuticals for alleged misstatements on device defects, regulatory prospects, and product timelines. Lead plaintiff deadline: April 7, 2026.
INOsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

Inovio Faces Securities Fraud Lawsuit Over Misleading Statements on Drug Candidate

Class action lawsuit filed against Inovio Pharmaceuticals ($INO) for allegedly making false statements about INO-3107 treatment and manufacturing capabilities, causing significant stock declines.
INOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Faruqi & Faruqi, Llp

Inovio Faces Securities Class Action Over Failed FDA Approval Strategy

Inovio Pharmaceuticals faces a securities class action over allegedly false statements regarding manufacturing capabilities and regulatory prospects for INO-3107, following FDA's December 29 accelerated approval rejection.
INOstock declinesecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Richtech Robotics Faces Class Action Lawsuit Over Microsoft Partnership Misrepresentation

Pomerantz Law Firm filed class action lawsuit against Richtech Robotics over alleged Microsoft partnership misrepresentation, citing 20.87% stock decline. Investors have until April 3, 2026, to join.
METCMETCBMETCIMETCZRR+1securities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Inovio Faces Securities Fraud Class Action Over Manufacturing Claims and FDA Setbacks

Pomerantz Law Firm files class action against $INO for alleged securities fraud involving false manufacturing capability and FDA approval claims for INO-3107.
INOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Ramaco Resources Faces Major Fraud Allegations; Class Action Lawsuit Filed Over Wyoming Mine Claims

Pomerantz Law Firm files class action against $METC following Wolfpack Research allegations of fraudulent Brook Mine operations, sparking 9.57% stock decline.
METCMETCBMETCIMETCZRR+1securities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Smart Digital Stock Crashes 86%, Triggering Class Action Lawsuit Over Alleged Fraud

$SDM plunges 86.4% after SEC suspension; class action lawsuit filed against Smart Digital Group and others for alleged securities fraud and social media market manipulation.
SDMRRINOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

BellRing Brands Faces Class Action Lawsuit Over Misleading Earnings Guidance

Pomerantz Law Firm sues BellRing Brands ($BRBR) for securities fraud over allegedly misleading earnings guidance and undisclosed inventory hoarding and capacity constraints.
BRBRRRINOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Law Offices Of Howard G. Smith

Four Major Companies Face Securities Fraud Lawsuits; Investors Eye April 2026 Deadlines

Four companies face securities fraud lawsuits alleging false business disclosures. Investors have until April 2026 to file lead plaintiff motions.
KDORCLORCLpDINOPSFEsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Schall Law Firm

Inovio Pharmaceuticals Hit with Securities Fraud Lawsuit Over Device Claims

Inovio Pharmaceuticals faces class action securities fraud lawsuit alleging false statements about manufacturing capabilities and regulatory timelines. Investors have until April 7, 2026 to join.
INOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Inovio Faces Securities Class Action Over Device Defects, Missed Regulatory Timelines

Rosen Law Firm files securities class action against Inovio Pharmaceuticals ($INO) alleging misleading statements on manufacturing deficiencies and overstated regulatory prospects. Lead plaintiff deadline April 7, 2026.
INOsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Camping World Under Fire in Securities Lawsuit Over Alleged Inventory, Demand Misstatements

Rosen Law Firm files class action lawsuit against Camping World Holdings over alleged misstatements regarding inventory management and consumer demand projections.
CWHINOTCOMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Inovio Faces Class Action Over Alleged Misstatements on Device Manufacturing and FDA Timeline

Class action lawsuit filed against Inovio Pharmaceuticals for allegedly making false statements about CELLECTRA device manufacturing and INO-3107 FDA submission timeline between October 2023 and December 2025.
INOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Class Action Lawsuits Filed Against $POMD and $INO Over Fraud Allegations

Class actions filed against PomDoctor for stock promotion fraud and Inovio for misleading regulatory claims. Inovio stock plunged 24.45% after FDA rejection.
INOPOMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Inovio Faces Securities Class Action Over Undisclosed Manufacturing Delays, FDA Review Setbacks

Law firm Levi & Korsinsky seeks investors in Inovio Pharmaceuticals securities class action alleging failure to disclose manufacturing delays and FDA's standard review decision.
INOsecurities class actionFDA approval
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Inovio Faces Securities Lawsuit Over Manufacturing Claims and Regulatory Missteps

Rosen Law Firm urges $INO investors to join class action lawsuit alleging false statements about manufacturing deficiencies and regulatory prospects.
INOsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Rosen Law Targets Ramaco Resources in Securities Fraud Case Over Brook Mine Claims

Rosen Law Firm pursues securities class action against $METC, alleging false statements about Brook Mine development progress. Lead plaintiff deadline set for March 31, 2026.
APOAPOSAPOpAMETCMETCB+3securities class actionlead plaintiff